Merle Ferguson - 13 Dec 2022 Form 4 Insider Report for BIOFORCE NANOSCIENCES HOLDINGS, INC. (BFNH)

Role
CEO, Director, 10%+ Owner
Signature
/s/ Merle Ferguson
Issuer symbol
BFNH
Transactions as of
13 Dec 2022
Transactions value $
$0
Form type
4
Filing time
14 Dec 2022, 09:27:24 UTC
Previous filing
03 Oct 2022
Next filing
09 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BFNH Common Stock Gift $0 -20,000 -0.12% $0 16,970,000 13 Dec 2022 Shares held in private company F1, F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Bona fide gift of securities given to a third-party which is not a relative or related business entity. Securities gifted from an indirect entity that the reporting person is an executive officer.
F2 Gift transaction, price not applicable.
F3 15,000,000 share are held directly by the reporting individual, 1,970,000 shares held indirectly in a business entity that the reporting person is an executive officer. Total direct and indirect beneficial ownership is 16,970,000.
F4 The reporting person is an Executive Officer of a private company, Trade Exchange International, Inc. Prior to the 20,000 share gift, Trade Exchange International, Inc. owned 1,990,000 share of the issuer; the current indirect holdings is now 1,970,000.